Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
J Headache Pain ; 25(1): 23, 2024 Feb 19.
Artigo em Inglês | MEDLINE | ID: mdl-38369488

RESUMO

OBJECTIVE: Medication overuse headache (MOH) was recently shown to be associated with leaky gut in rodents. We aimed to investigate whether chronic migraine (CM) patients with MOH have elevated lipopolysaccharide levels and inflammatory molecules in blood circulation. MATERIALS AND METHODS: The study included women participants (40 CM patients with NSAID overuse headache, 35 episodic migraine (EM) patients, and 20 healthy non-headache sufferers). Migraine duration, monthly migraine headache days, MigSCog, HADS-D, HADS-A, and HIT-6 scores were recorded. Serum samples were collected to measure circulating LPS, LPS binding protein (LBP), tight junction protein occludin, adherens junction protein vascular endothelial cadherin (VE-cadherin), CGRP, HMGB1, HIF-1α, IL-6, and IL-17 levels. RESULTS: Serum LPS, VE-Cadherin, CGRP, HIF-1α, and IL-6 levels were significantly higher in the CM + MOH group compared to the EM group and healthy controls while serum LBP and HMGB1 were higher in the CM + MOH group compared to healthy controls. IL-17 and occludin levels were comparable between the three groups. Serum HMGB1 levels in EM patients were higher compared to the control group. Mig-SCog and HIT-6 scores were higher in the CM + MOH group compared to EM patients. HADS-A and HADS-D scores were significantly higher in the CM + MOH group compared to EM patients and healthy controls, and they were also higher in EM patients compared to healthy subjects. LPS levels were correlated with VE-cadherin and occludin levels. The number of monthly migraine headache days was positively correlated with serum LPS, HIF-1α, VE-cadherin, and IL-6 levels, HADS-A, HADS-D, HIT-6, and MigSCog scores. CONCLUSION: We have evidence for the first time that CM + MOH is associated with elevated serum LPS and LBP levels suggestive of LPS leak into the systemic circulation. Higher levels of nociceptive and/or pro-inflammatory molecules such as HMGB1, HIF-1α, IL-6, and CGRP may play a role in trigeminal sensitization and neurobiology of MOH. Intestinal hyperpermeability and consequent inflammatory response should be considered as a potential contributory factor in patients with MOH.


Assuntos
Antígenos CD , Caderinas , Proteína HMGB1 , Transtornos da Cefaleia Secundários , Transtornos de Enxaqueca , Feminino , Humanos , Antígenos CD/sangue , Caderinas/sangue , Peptídeo Relacionado com Gene de Calcitonina/sangue , Transtornos da Cefaleia Secundários/sangue , Proteína HMGB1/sangue , Inflamação/complicações , Interleucina-17/sangue , Interleucina-6/sangue , Lipopolissacarídeos/sangue , Transtornos de Enxaqueca/sangue , Ocludina/sangue
2.
Turk J Med Sci ; 54(1): 33-41, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38812640

RESUMO

Background/aim: Medication overuse is common among chronic migraine patients and nonsteroidal antiinflammatory drugs (NSAIDs) are the most frequently overused drugs. The pathophysiological mechanisms underlying medication overuse headache (MOH) are not completely understood. Intestinal hyperpermeability and leaky gut are reported in patients using NSAIDs. The aim of the study is to investigate the role of leaky gut and inflammation in an MOH model MOH model in male rats. Methods: The study was conducted in male Sprague Dawley rats. There were two experimental groups. The first group was the chronic NSAID group in which the rats received mefenamic acid (n = 8) for four weeks intraperitoneally (ip) and the second group was the vehicle group (n = 8) that received 5% dimethyl sulfoxide+sesame oil (ip) for 4 weeks. We assessed spontaneous pain-like behavior, periorbital mechanical withdrawal thresholds, and anxiety-like behavior using an elevated plus maze test. After behavioral testing, serum levels of occludin and lipopolysaccharide-binding protein (LBP) and brain levels of IL-17, IL-6, and high mobility group box 1 protein (HMGB1) were evaluated with ELISA.Results: Serum LBP and occludin levels and brain IL-17 and HMGB1 levels were significantly elevated in the chronic NSAID group compared to its vehicle (p = 0.006, p = 0.016, p = 0.016 and p = 0.016 respectively) while brain IL-6 levels were comparable (p = 0.67) between the groups. The chronic NSAID group showed pain-like and anxiety-like behavior in behavioral tests. Brain IL-17 level was positively correlated with number of head shakes (r = 0.64, p = 0.045), brain IL-6 level was negatively correlated with periorbital mechanical withdrawal thresholds (r = -0.71, p = 0.049), and serum occludin level was positively correlated with grooming duration (r = 0.73, p = 0.032) in chronic NSAID group. Conclusion: Elevated serum occludin and LBP levels and brain IL-17 and HMGB1 levels indicate a possible role of leaky gut and inflammation in an MOH model in male rats. Additionally, a significant correlation between pain behavior and markers of inflammation and intestinal hyperpermeability, supports the role of inflammation and leaky gut in MOH pathophysiology.


Assuntos
Anti-Inflamatórios não Esteroides , Biomarcadores , Proteínas de Transporte , Modelos Animais de Doenças , Transtornos da Cefaleia Secundários , Interleucina-17 , Ratos Sprague-Dawley , Animais , Masculino , Ratos , Biomarcadores/sangue , Transtornos da Cefaleia Secundários/sangue , Interleucina-17/sangue , Interleucina-17/metabolismo , Proteínas de Transporte/sangue , Proteínas de Transporte/metabolismo , Ocludina/metabolismo , Glicoproteínas de Membrana/sangue , Glicoproteínas de Membrana/metabolismo , Proteína HMGB1/sangue , Proteína HMGB1/metabolismo , Interleucina-6/sangue , Inflamação/sangue , Inflamação/metabolismo , Encéfalo/metabolismo , Encéfalo/efeitos dos fármacos , Proteínas de Fase Aguda
3.
Int J Mol Sci ; 22(16)2021 Aug 21.
Artigo em Inglês | MEDLINE | ID: mdl-34445731

RESUMO

Chronic headache is a topical problem of neurology, psychiatry and general practice. The medication-overuse headache (MOH) is one of the leading pathologies in the structure of chronic headache. However, early diagnosis of the MOH is challenging. We analyzed potential proteomic biomarkers of serum and urine in patients with MOH. METHODS: We searched PubMed, Springer, Scopus, Web of Science, ClinicalKey, and Google Scholar databases for English publications over the past 10 years using keywords and their combinations. RESULTS: We found and analyzed seven studies that met the search criteria for the purpose of the review, including 24 serum proteomic biomarkers and 25 urine proteomic biomarkers of MOH. Moreover, the candidate genes and locus of the studied serum (vitamin D-binding protein, lipocalin-type prostaglandin D2 synthase, apolipoprotein E, etc.) and urine proteomic biomarkers (uromodulin, alpha-1-microglobulin, zinc-alpha-2-glycoprotein, etc.) of MOH are presented in this review. CONCLUSIONS: The serum and urine proteomic biomarkers of MOH can potentially help with the identification of patients with MOH development. Due to the relevance of the problem, the authors believe that further investigation of the MOH proteomic biomarkers in different ethnic and racial groups of patients with primary headache is necessary. In addition, it is important to investigate whether medications of different drug classes influence the levels of serum and urine proteomic biomarkers.


Assuntos
Biomarcadores/sangue , Biomarcadores/urina , Transtornos da Cefaleia Secundários/sangue , Transtornos da Cefaleia Secundários/urina , Proteoma , Dor Crônica/sangue , Dor Crônica/tratamento farmacológico , Dor Crônica/genética , Dor Crônica/urina , Transtornos da Cefaleia Secundários/induzido quimicamente , Transtornos da Cefaleia Secundários/genética , Humanos
4.
Cephalalgia ; 40(10): 1070-1078, 2020 09.
Artigo em Inglês | MEDLINE | ID: mdl-32347744

RESUMO

PURPOSE OF THE STUDY: The pathophysiological mechanism of medication overuse headache is uncertain; no distinctive markers have been described right now. The aim of this study was to conduct proteomic analyses on serum samples from patients with medication overuse headache and healthy individuals. Specifically, mono- (SDS-PAGE) and two-dimensional gel electrophoresis (2-DE) followed by liquid chromatography tandem mass spectrometry (LC-MS/MS) were used to evaluate changes in serum proteins. MAIN FINDINGS: By SDS-PAGE, four over-expressed bands were revealed in patients, compared to controls. 2-DE combined with LC-MS/MS analysis allowed confirmation of some proteins preliminarily detected by SDS-PAGE: Hemopexin, alpha-1-acid glycoprotein 1, apolipoprotein A4 and haptoglobin. Moreover, other differential proteins were isolated, mostly increased in MOH patients: Alpha-1-antitrypsin, immunoglobulin heavy constant alpha 1, retinol binding protein and transthyretin. Only one protein, immunoglobulin kappa constant, was decreased in the patients' group. CONCLUSIONS: The investigation of the serum proteome can offer a better understanding about biological mechanisms underlying medication overuse headache. Specifically, medication overuse headache shares some serum biochemical markers with chronic pain conditions. Further studies might uncover the relevance of these proteins in medication overuse headache.


Assuntos
Biomarcadores/sangue , Transtornos da Cefaleia Secundários/sangue , Adulto , Idoso , Cromatografia Líquida/métodos , Eletroforese em Gel Bidimensional/métodos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Proteômica/métodos , Espectrometria de Massas em Tandem/métodos
5.
Headache ; 60(8): 1664-1672, 2020 09.
Artigo em Inglês | MEDLINE | ID: mdl-32790215

RESUMO

OBJECTIVE: In this study, we aimed to evaluate the frequency of the main red flags in patients with headache who do have Covid-19. BACKGROUND: Headache is one of the most frequent neurologic symptoms of Coronavirus disease 2019 (Covid-19). Diagnosis of secondary headache disorders is still based on the presence of red flags. DESIGN AND METHODS: Cross-sectional study of hospitalized patients with confirmed Covid-19 disease. We interrogated every patient about the presence of headache and if so, a headache expert conducted a structured interview assessing the presence and type of the main red flags. We evaluated the presence of laboratory abnormalities on admission. RESULTS: We screened 576 consecutive patients, 130/576 (22.6%) described headache, and 104 were included in the study. Mean age of patients was 56.7 (standard deviation: 11.2) and 66/104 (63.4%) were female. Red flags concerning prior medical history were present in 79/104 (76.0%) cases, and those related to the headache itself were observed in 99/104 (95.2%) patients. All patients 104/104 (100%) described systemic symptoms and 86/104 (82.7%) some neurologic symptoms. Laboratory results were abnormal in 98/104 (94.2%) cases. The most frequent red flags were fever, in 93/104 (89.4%) patients, cough, in 89/104 (85.6% cases), and increased C-reactive protein in 84/100 (84.0%) cases. CONCLUSION: In patients with Covid-19 that described the headache red flags were present in most cases. There was not any universal red flag, being necessary the comprehensive evaluation of all of them.


Assuntos
Proteína C-Reativa/análise , COVID-19/complicações , Tosse/etiologia , Febre/etiologia , Transtornos da Cefaleia Secundários/etiologia , Pacientes Internados , Doenças do Sistema Nervoso/etiologia , SARS-CoV-2 , Fatores Etários , Idoso , Biomarcadores , COVID-19/sangue , COVID-19/diagnóstico , COVID-19/epidemiologia , Teste para COVID-19/métodos , Doenças Cardiovasculares/epidemiologia , Comorbidade , Estudos Transversais , Diabetes Mellitus/epidemiologia , Exantema/etiologia , Feminino , Gastroenteropatias/etiologia , Cefaleia/epidemiologia , Transtornos da Cefaleia Secundários/sangue , Transtornos da Cefaleia Secundários/diagnóstico , Transtornos da Cefaleia Secundários/epidemiologia , Hospitalização , Humanos , Masculino , Pessoa de Meia-Idade , Dor/etiologia , Espanha/epidemiologia , Avaliação de Sintomas
6.
Cephalalgia ; 39(5): 655-664, 2019 04.
Artigo em Inglês | MEDLINE | ID: mdl-30213202

RESUMO

AIM: To address whether, in patients with chronic migraine and medication overuse headache, mindfulness-based treatment is associated with changes in plasma levels of catecholamines and elusive amines that are similar to those observed in patients undergoing pharmacological prophylaxis. METHODS: In this non-randomized, clinic-based effectiveness study, patients aged 18-65, with a history of chronic migraine ≥ 10 years and overuse of triptans or non-steroidal anti-inflammatory drugs ≥ 5 years, were enrolled. Upon completion of a structured withdrawal program, patients received either pharmacological prophylaxis or six weekly sessions of mindfulness-based treatment and were followed for 12 months. Daily headache diaries were used to record headache frequency and medication intake; catecholamines (noradrenaline, epinephrine and dopamine) and levels of elusive amines were assayed from poor platelet plasma. RESULTS: Complete follow-up data were available for 15 patients in the pharmacological prophylaxis-group (14 females, average age 44.1) and 14 in the mindfulness treatment-group (all females, average age 46.4), and all variables were comparable between groups at baseline. At 12 months, significant improvement ( p < .001) was found in the pharmacological prophylaxis group for headache frequency and medication intake (by 51% and 48.7%, respectively), noradrenaline, epinephrine and dopamine (by 98.7%, 120.8% and 501.9%, respectively); patients in the mindfulness treatment-group performed similarly. For elusive amines, no longitudinal changes were found. CONCLUSIONS: The similar improvement trends observed in the two groups of patients further support the utility of mindfulness-based treatment in migraine care, and reinforce the hypothesis that alteration and normalization of tyrosine metabolism are implicated in migraine chronification and in remission of chronic migraine.


Assuntos
Analgésicos/uso terapêutico , Catecolaminas/sangue , Transtornos da Cefaleia Secundários/terapia , Transtornos de Enxaqueca/terapia , Atenção Plena , Adulto , Feminino , Transtornos da Cefaleia Secundários/sangue , Humanos , Masculino , Pessoa de Meia-Idade , Transtornos de Enxaqueca/sangue , Projetos Piloto , Resultado do Tratamento
7.
BMC Neurol ; 19(1): 239, 2019 Oct 17.
Artigo em Inglês | MEDLINE | ID: mdl-31623575

RESUMO

BACKGROUND: Medication Overuse Headache (MOH) is a prevalent and disabling disorder resulting from the overuse of analgesic drugs, triptans or other acute headache medications. In previous proteomic studies, several proteins have been found at high concentrations in the urine of MOH patients and in the serum of rats with neuropathic pain. The aim of this study was to compare the serum levels of lipocalin-type Prostaglandin D2 synthase (L-PGDS), Vitamin D-binding protein (VDBP), apolipoprotein E (APOE) and apolipoprotein A1 (APOA1) in MOH patients and healthy individuals, further exploring their relationship with cutaneous pain thresholds (CPTs) in the territories innervated by the trigeminal nerve. METHODS: Sixty-nine MOH patients and 42 age- and sex-matched healthy volunteers were enrolled in the study. Von Frey-like filaments were applied to the skin territories innervated by the trigeminal nerve, to determine the CPTs. L-PGDS, VDBP, APOE and APOA1 were quantified in the serum by Enzyme-linked Immunosorbent Assay (ELISA). Clinical and laboratory data were collected. Comparisons between MOH patients and healthy individuals were performed using independent t test or χ2 test. To correlate serum proteins with CPTs, Pearson correlation coefficient or Spearman's rank correlation coefficient were used. RESULTS: CPTs were lower among MOH patients. L-PGDS, VDBP and APOE had significantly different serum concentrations between groups (p < 0.01), but no correlation was found with CPTs. APOA1 serum concentrations did not differ between patients and healthy individuals. CONCLUSIONS: L-PGDS, VDBP and APOE had abnormal serum levels in MOH patients, confirming their alteration in some conditions of chronic headache and neuropathic pain. However, they had no relationship with CPTs. The in-depth study of serum proteins represents a promising approach for a better understanding of MOH, as well as the detection of candidate biomarkers for chronic headache or the risks associated with overuse medications.


Assuntos
Biomarcadores/sangue , Transtornos da Cefaleia Secundários/sangue , Adulto , Animais , Dor Crônica/sangue , Feminino , Transtornos da Cefaleia/sangue , Humanos , Masculino , Pessoa de Meia-Idade , Proteômica , Ratos
8.
Acta Neurol Scand ; 139(3): 269-275, 2019 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-30457160

RESUMO

BACKGROUND: Previous studies found low serum levels of nociceptin in migraine patients but high serum levels of calcitonin gene-related peptide (CGRP). CGRP can elicit migraine-like headache. Medication-Overuse Headache (MOH) often has migraine features and can mimic chronic migraine. We therefore hypothesized that as in migraine, serum levels of nociceptin would be lower and CGRP serum levels higher in MOH patients compared with those in healthy volunteers. We hypothesized that the serum levels would normalize after detoxification. METHODS: Seventeen MOH patients, hereof 70.6% with chronic migraine and MOH, and 30 sex and age matched headache-free controls were included. MOH patients underwent a 2-month outpatient detoxification program and after 6 months, 10 patients and 19 controls were retested. Blood samples were analyzed blinded. RESULTS: We found no differences in the levels of nociceptin and CGRP between MOH patients and controls (P = 0.65 and P = 0.59). The mean headache frequency reduction was 43% and 70% of patients reverted to episodic headache after 6 months, but the levels of nociceptin and CGRP were unchanged (P = 0.71 and P = 0.82). CONCLUSION: In contrast to previous findings in migraine patients, we found normal serum levels of nociceptin and CGRP in MOH patients. Thus, we find no evidence that the increased headache frequency of MOH patients could be caused by altered nociceptin and CGRP levels. This underlines the importance of identifying medication overuse in chronic headache and treating the MOH.


Assuntos
Peptídeo Relacionado com Gene de Calcitonina/sangue , Transtornos da Cefaleia Secundários/sangue , Peptídeos Opioides/sangue , Adulto , Feminino , Transtornos da Cefaleia Secundários/tratamento farmacológico , Humanos , Masculino , Pessoa de Meia-Idade , Nociceptina
9.
Neurol Sci ; 38(Suppl 1): 173-175, 2017 May.
Artigo em Inglês | MEDLINE | ID: mdl-28527073

RESUMO

Chronic migraine (CM) is a disabling condition arising from a complex mixture of interconnected biological, psychological and social factors, and is often associated with medication overuse (MO). Mindfulness is emerging as a helpful treatment for pain, and one study showed that the longitudinal 12 months' course of CM-MO patients that attended mindfulness-based treatment alone was similar to that of patients receiving medical prophylaxis alone; in this study, we describe the course of biomarkers of inflammation. Our results provide initial evidence of sustained similar effects on reduced concentration of biomarkers of inflammation, although not sizeable enough to reach statistical significance. Whether more intensive treatment and/or larger samples would lead to greater changes is unknown, but these encouraging preliminary findings suggest further research is warranted.


Assuntos
Transtornos da Cefaleia Secundários/sangue , Transtornos da Cefaleia Secundários/terapia , Transtornos de Enxaqueca/sangue , Transtornos de Enxaqueca/terapia , Atenção Plena/métodos , Profilaxia Pré-Exposição/métodos , Adolescente , Adulto , Idoso , Analgésicos/administração & dosagem , Anti-Inflamatórios não Esteroides/efeitos adversos , Biomarcadores/sangue , Doença Crônica , Feminino , Seguimentos , Transtornos da Cefaleia Secundários/diagnóstico , Humanos , Inflamação/sangue , Inflamação/diagnóstico , Inflamação/terapia , Masculino , Pessoa de Meia-Idade , Transtornos de Enxaqueca/diagnóstico , Síndrome de Abstinência a Substâncias/sangue , Síndrome de Abstinência a Substâncias/terapia , Fatores de Tempo , Resultado do Tratamento , Triptaminas/efeitos adversos , Adulto Jovem
10.
Headache ; 55(7): 984-91, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26129705

RESUMO

BACKGROUND: Migraine is a complex multifactorial, neurobiological disorder, whose pathogenesis is not fully understood, nor are the mechanisms associated with migraine transformation from episodic to chronic pattern. A possible role of impaired oxidative mitochondrial metabolism in migraine pathogenesis has been hypothesized, and increased levels of peripheral markers of oxidative stress have been reported in migraine patients, although the literature data are limited and heterogeneous. OBJECTIVES: The aim of this cross-sectional study was to determine plasmatic levels of advanced oxidation protein products, ferric-reducing antioxidant power and total plasmatic thiol groups, all plasmatic markers related to oxidative stress, in a sample of chronic migraine patients and medication-overuse headache, compared to a control group of healthy subjects. METHODS: Thirty-three patients with a diagnosis of both chronic migraine and medication-overuse headache (International Classification of Headache Disorders,3rd edition, beta version) and 33 healthy, headache-free subjects were enrolled. Patients with comorbid/coexisting conditions were excluded, as well as patients in treatment with migraine preventive drugs. Plasmatic levels of advanced oxidation protein products, ferric-reducing antioxidant power, and total thiol groups were determined in migraine patients and controls; moreover, oxidative stress biomarkers were compared in migraine patients with triptan compared to non-steroidal anti-inflammatory drug overuse. RESULTS: The statistical analysis showed significantly lower levels of ferric-reducing antioxidant power and total plasmatic thiol groups, both expression of antioxidant power, in patients with chronic migraine and medication-overuse headache compared to controls (respectively, ferric antioxidant power median [interquartile range] 0.53 [0.22] vs 0.82 [0.11] mmol/L, P < .001; total thiol groups 0.25 [0.08] vs 0.51 [0.11] µmol/L, P < .001). Moreover, no statistically significant differences in oxidative stress biomarkers were detected between patients with triptan and nonsteroidal anti-inflammatory drug overuse. CONCLUSIONS: The data from the present study suggest that antioxidant capacity is lower in chronic migraine patients and medication-overuse headache compared to healthy headache-free subjects, with no differences between patients with triptan or nonsteroidal anti-inflammatory drug overuse. Further investigation is certainly necessary in order to define the causal or consequential role of an imbalance between pro-oxidants and antioxidant defenses in migraine pathogenesis and "chronification" and the possible therapeutic implications in clinical practice.


Assuntos
Produtos da Oxidação Avançada de Proteínas/sangue , Transtornos da Cefaleia Secundários/metabolismo , Transtornos de Enxaqueca/metabolismo , Estresse Oxidativo , Adulto , Produtos da Oxidação Avançada de Proteínas/metabolismo , Idoso , Anti-Inflamatórios não Esteroides/efeitos adversos , Anti-Inflamatórios não Esteroides/uso terapêutico , Biomarcadores/sangue , Doença Crônica , Estudos Transversais , Feminino , Transtornos da Cefaleia Secundários/sangue , Humanos , Masculino , Pessoa de Meia-Idade , Transtornos de Enxaqueca/sangue , Transtornos de Enxaqueca/tratamento farmacológico , Agonistas do Receptor de Serotonina/efeitos adversos , Agonistas do Receptor de Serotonina/uso terapêutico , Triptaminas/efeitos adversos , Triptaminas/uso terapêutico
11.
Neurobiol Dis ; 30(2): 186-9, 2008 May.
Artigo em Inglês | MEDLINE | ID: mdl-18358734

RESUMO

Chronic migraine (CM) is frequently associated with medication overuse headache (MOH). The endocannabinoid system plays a role in modulating pain including headache and is involved in the common neurobiological mechanism underlying drug addiction and reward system. Anandamide (AEA) and 2-arachidonoylglycerol are the most biologically active endocannabinoids, which bind to both central and peripheral cannabinoid receptors. The level of AEA in the extracellular space is controlled by cellular uptake via a specific AEA membrane transporter (AMT), followed by intracellular degradation by the enzyme AEA hydrolase (fatty acid amide hydrolase, FAAH). AMT and FAAH have also been characterized in human platelets. We assayed the activity of AMT and of FAAH in platelets isolated from four groups of subjects: MOH, CM without MOH, episodic migraine and controls. AMT and FAAH were significantly reduced in CM and MOH, compared to either controls or episodic migraine group. This latter finding was observed in both males and females with CM and MOH. Changes observed in the biochemical mechanisms degrading endogenous cannabinoids may reflect an adaptative behaviour induced by chronic headache and/or drug overuse.


Assuntos
Moduladores de Receptores de Canabinoides/sangue , Endocanabinoides , Transtornos da Cefaleia Secundários/sangue , Transtornos de Enxaqueca/sangue , Adulto , Doença Crônica , Feminino , Transtornos da Cefaleia Secundários/diagnóstico , Humanos , Masculino , Pessoa de Meia-Idade , Transtornos de Enxaqueca/diagnóstico
12.
Med Clin North Am ; 97(2): 217-24, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23419622

RESUMO

Blood tests have a minor role in headache management and that role is limited to a few secondary headache conditions. In headache, as with any symptom, laboratory tests should be chosen based on solid clues derived from the targeted history and physical examination. A shotgun approach to blood tests that includes rare diseases or those with low local prevalence frequently yields false-positive results, which exposes the patient to the expense, anxiety, and risk inherent in misdiagnosis. Keep it simple and do not forget about spinal fluid.


Assuntos
Transtornos da Cefaleia Secundários/etiologia , Exame Físico/métodos , Líquido Cefalorraquidiano , Diagnóstico Diferencial , Transtornos da Cefaleia Secundários/sangue , Testes Hematológicos , Humanos , Detecção do Abuso de Substâncias
13.
Headache ; 46(4): 597-603, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16643554

RESUMO

OBJECTIVE: To evaluate the effects of analgesic overuse on endocrine function in patients with chronic migraine and medication-overuse headache (CM-MOH). BACKGROUND: Chronic migraine is frequently associated with an overuse of symptomatic medications. Drugs currently used in acute migraine attacks are associated with several endocrine effects. At present, the endocrine effects of medication overuse in chronic migraine patients are unknown. METHODS: Eighteen patients with CM-MOH, diagnosed according to the ICHD-II criteria, and 18 healthy controls received an intravenous administration of GHRH, hCRH, and TRH. Plasma concentrations of GH, TSH, ACTH, and cortisol were measured for a 90-minute period after administration of the specific releasing hormones. RESULTS: Hormonal basal concentrations were similar in both groups. GH response to GHRH was significantly reduced in patients with CM-MOH in comparison with controls. TRH induced a reduction of TSH concentrations only at the end of the test. After hCRH administration, ACTH and cortisol concentrations were significantly higher in cases than in controls. A significant correlation between duration of the disease and altered hormonal response was found. CONCLUSIONS: Our study shows that both corticotropic and somatotropic functions are significantly impaired in CM-MOH patients and suggests a role for hormones in the development of chronic migraine.


Assuntos
Hormônio Liberador da Corticotropina/administração & dosagem , Hormônio Liberador de Hormônio do Crescimento/administração & dosagem , Transtornos da Cefaleia Secundários/fisiopatologia , Transtornos de Enxaqueca/fisiopatologia , Hormônio Liberador de Tireotropina/administração & dosagem , Hormônio Adrenocorticotrópico/sangue , Adulto , Área Sob a Curva , Doença Crônica , Hormônio Liberador da Corticotropina/farmacocinética , Glândulas Endócrinas/metabolismo , Feminino , Hormônio do Crescimento/sangue , Hormônio Liberador de Hormônio do Crescimento/farmacocinética , Transtornos da Cefaleia Secundários/sangue , Transtornos da Cefaleia Secundários/complicações , Humanos , Hidrocortisona/sangue , Masculino , Pessoa de Meia-Idade , Transtornos de Enxaqueca/sangue , Transtornos de Enxaqueca/complicações , Tireotropina/sangue , Hormônio Liberador de Tireotropina/farmacocinética
14.
Pharmacol Res ; 54(2): 142-9, 2006 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16697657

RESUMO

BACKGROUND: The combination of indomethacin, prochlorperazine and caffeine (IPC) is one of the most utilized formulations for the treatment of migraine attacks in Italy. Several patients suffering from chronic headache overuse this symptomatic medication in the attempt to control their headache. OBJECTIVE: To verify whether overuse of IPC combination by chronic headache patients is associated with modified disposition of its components. METHODS: We studied indomethacin, prochlorperazine, and caffeine disposition in 34 female subjects suffering from primary headaches, subdivided into four groups: eight migraine patients occasionally using IPC combination suppositories-group 1; nine patients with chronic headache and probable medication-overuse headache, daily taking one or more suppositories of the IPC combination-group 2; 11 migraine patients occasionally using "mild" suppositories of the IPC combination-group 3; six migraine patients occasionally taking tablets of the IPC combination-group 4. The IPC combination habitually used was administered to each patient. Blood samples were taken at baseline and at fixed intervals up to 6h after administration. Plasma levels of indomethacin and prochlorperazine were assayed by high-pressure liquid chromatographic (HPLC) method; caffeine levels were assayed by enzyme multiplied immunoassay test (EMIT). Pharmacokinetic parameters were calculated by means of a computer software (P K Solutions 2.0. Summit Research Services, Montrose, CO, USA). RESULTS: Half-life of indomethacin was longer, and clearance lower, in group 2 than in the other groups; AUC of indomethacin in group 2 was twice that in group 1 (P<0.05, Newman-Keuls' test). Peak concentrations and AUC(0-->infinity) of caffeine were significantly higher in group 2 than in the other groups (P<0.05, Newman-Keuls' test). We could not define prochlorperazine disposition because it was not detectable in the majority of blood samples. CONCLUSION: Overuse of IPC combination in chronic headache patients is associated with increased plasma levels of indomethacin and caffeine, and with delayed elimination of indomethacin; the high and sustained concentrations of these drugs may cause rebound headache, organ damages, and perpetuate medication-overuse headache.


Assuntos
Cafeína/uso terapêutico , Transtornos da Cefaleia Secundários/tratamento farmacológico , Transtornos da Cefaleia/tratamento farmacológico , Indometacina/uso terapêutico , Proclorperazina/uso terapêutico , Anti-Inflamatórios não Esteroides/farmacocinética , Anti-Inflamatórios não Esteroides/uso terapêutico , Antipsicóticos/farmacocinética , Antipsicóticos/uso terapêutico , Área Sob a Curva , Cafeína/farmacocinética , Estimulantes do Sistema Nervoso Central/farmacocinética , Estimulantes do Sistema Nervoso Central/uso terapêutico , Doença Crônica , Combinação de Medicamentos , Feminino , Meia-Vida , Transtornos da Cefaleia/sangue , Transtornos da Cefaleia/induzido quimicamente , Transtornos da Cefaleia/fisiopatologia , Transtornos da Cefaleia Secundários/sangue , Transtornos da Cefaleia Secundários/induzido quimicamente , Transtornos da Cefaleia Secundários/fisiopatologia , Humanos , Indometacina/farmacocinética , Pessoa de Meia-Idade , Proclorperazina/farmacocinética , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA